Francesca Bartoli
Florence, 50139, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases.
Journal: Biomedicines
Published: June 26, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65).
Journal: Journal of personalized medicine
Published: May 03, 2024
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice.
Journal: Journal of personalized medicine
Published: August 01, 2023
Persistence of remission after lengthening of golimumab in inflammatory joint diseases.
Journal: Clinical and experimental rheumatology
Published: March 23, 2022
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases.
Journal: European journal of rheumatology
Published: February 03, 2022
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life.
Journal: Clinical rheumatology
Published: August 30, 2021
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience.
Journal: Autoimmunity reviews
Published: July 09, 2021
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis.
Journal: Therapeutic advances in musculoskeletal disease
Published: December 16, 2020
Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience.
Journal: Therapeutic advances in musculoskeletal disease
Published: November 04, 2020
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience.
Journal: Rheumatology and immunology research
Published: June 12, 2020
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.
Journal: Therapeutic advances in musculoskeletal disease
Published: May 09, 2020
Last Updated: 09/26/2026